The Spectrum of Functional, Structural and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration – A MACUSTAR Study Report
Ophthalmologica · 2025
DOI: 10.1159/000543231 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Ophthalmologica, 2025. Verfasst von Jan Henrik Terheyden und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital Bonn, Bonn, Germany, jan.terheyden@ukbonn.de. Hauptthemen laut MEDLINE: Visual Acuity, Tomography, Optical Coherence, Patient Reported Outcome Measures, Macular Degeneration. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
There is an unmet medical need for therapies in intermediate age-related macular degeneration (iAMD). The prospective European multi-center cohort study MACUSTAR validates structural, functional and patient-reported iAMD endpoints for use in future trials. The multiplicity of assessments allows characterizing iAMD in more dimensions than previously available. We describe the heterogeneity of assessments in the iAMD baseline cohort of the MACUSTAR study.
Methods
A wide range of assessments were administered across 20 European study sites in accordance with established guidelines. These assessments encompassed multiple structural evaluations, such as color fundus photography, fundus autofluorescence, and optical coherence tomography. Additionally, functional tests were conducted, including assessments of best-corrected and low-luminance visual acuity (VA), Moorfields acuity, contrast sensitivity, reading speed, mesopic and scotopic microperimetry, and dark adaptometry. Moreover, patient-reported outcome assessments, specifically the Vision Impairment in Low Luminance questionnaire, were also incorporated into the evaluation process. Associations between variables were investigated using Phi coefficients, Pearson correlation coefficients and age-corrected regression models.
Results
Five-hundred eighty-five individuals with iAMD (66% women; mean (standard deviation) age: 72±7 years) were included in the MACUSTAR study. Forty-nine percent had pigmentary abnormalities, 27% had reticular pseudodrusen; 10% and 9% had incomplete and complete retinal pigment epithelium and outer retinal atrophy at baseline, respectively. Mean best-corrected VA, low-luminance VA and mesopic average threshold on microperimetry at baseline were 0.03±0.11 logMAR, 0.24±0.16 logMAR and 23.3±3.7 dB. Mean VILL subscale scores at baseline were 2±2 to 2±3 logits. Phi coefficients between structural assessments ranged between 0.17 and 0.22 (median 0.21); correlation coefficients between function tests ranged between 0.07 and 0.69 (median 0.34) and between VILL scores ranged between 0.21 and 0.68 (median 0.23).
Conclusion
The findings from this broad and comprehensive spectrum of assessments of structure, function, and patient-reported outcomes in iAMD suggest that the disease spectrum is diverse and heterogeneous and that further efforts are necessary to fully understand and characterize iAMD in all its complexities. A further in-depth characterization will enable novel enrichment strategies for clinical trials in iAMD.
Trial registration
ClinicalTrials.gov, NCT03349801. Registered on November 22, 2017
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital Bonn, Bonn, Germany, jan.terheyden@ukbonn.de.
- Department of Ophthalmology, University Hospital Bonn, Bonn, Germany.
- GRADE Reading Center, Bonn, Germany.
- Informatics and Epidemiology, Medical Faculty, Institute for Medical Biometry, University of Bonn, Bonn, Germany.
- UCL Institute of Ophthalmology, University College London, London, UK.
- Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.
Zitieren
APA
Terheyden, J. H., Holz, F. G., Behning, C., Dunbar, H. M. P., Schmitz-Valckenberg, S., Tufail, A., Schmid, M., Crabb, D. P., Saßmannshausen, M., Binns, A., Hoyng, C. B., Zakaria, N., Poor, S., Moll, K. P., Cosette, D., Martinho, C., Batuca, J., Cunha-Vaz, J., Luhmann, U. F. O., …, & MACUSTAR consortium (2025). The Spectrum of Functional, Structural and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration – A MACUSTAR Study Report. Ophthalmologica. https://doi.org/10.1159/000543231
Vancouver
Terheyden JH, Holz FG, Behning C, Dunbar HMP, Schmitz-Valckenberg S, Tufail A, et al. The Spectrum of Functional, Structural and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration – A MACUSTAR Study Report. Ophthalmologica. 2025. doi:10.1159/000543231
BibTeX
@article{Terheyden2025,
author = {Terheyden, Jan Henrik and Holz, Frank G and Behning, Charlotte and Dunbar, Hannah M P and Schmitz-Valckenberg, Steffen and Tufail, Adnan and Schmid, Matthias and Crabb, David P and Saßmannshausen, Marlene and Binns, Alison and Hoyng, Carel B and Zakaria, Nadia and Poor, Stephen and Moll, Klaus-Peter and Cosette, Deborah and Martinho, Cecília and Batuca, Joana and Cunha-Vaz, José and Luhmann, Ulrich F O and Leal, Sergio and Finger, Robert P and MACUSTAR consortium, MACUSTAR consortium},
title = {The Spectrum of Functional, Structural and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration – A MACUSTAR Study Report},
journal = {Ophthalmologica},
year = {2025},
doi = {10.1159/000543231}
}
EUVIMED